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Epigenetics is a phenomenon of heritable changes in the chromatin structure of a genomic region, resulting in a transcriptional
silent or active state of the region over cell mitosis. Mounting evidence has demonstrated phenotypic consequence of alternations
in the patterns of DNA methylation and histone modiﬁcations, two of the well-studied epigenetic mechanisms. The epigenome
thus represents an interesting therapeutic target. Traditional Chinese medicine (TCM) is a system of therapies that has developed
through empiricism for over 2100 years and has remained a popular alternative medicine in some Far East Asian populations.
We searched 3294 TCM medicinals (TCMMs) containing 48491 chemicals for chemicals that interact with the epigenetics-
related proteins and found that 29.8% of the TCMMs are epigenome- and miRNA-modulating via, mainly, interactions with
Polycomb group and methyl CpG-binding proteins. We analyzed 200 government-approved TCM formulas (TCMFs) and found
that a statistically signiﬁcant proportion (99%) of them are epigenome- and miRNA-interacting. The epigenome and miRNA
interactivity oftheMonarchmedicinalsisfoundto be mostprominent.Histonemodiﬁcationsareheavilyexploited bytheTCMFs,
many of which are tonic. Furthermore, epigenetically, the Assistant medicinals least resemble the Monarch. We quantiﬁed the
role of epigenetics in TCM prescription and found that epigenome- and miRNA-interaction information alone determined, to
an extent of 20%, the clinical application areas of the TCMFs. Our results provide (i) a further support for the notion of the
epigenomes as a drug target and (ii) a new set of tools for the design of TCM prescriptions.
1.Introduction
According to a recent survey, 40% US adults had at least
once used alternative and complementary medicine (CAM)
therapy during a 1-year span [1]. The prevalence of CAM
among adults >65 years old was even higher at 63%
[2]. Traditional Chinese medicine (TCM) is a system of
theories and therapies that was ﬁrst documented in ancient
Chinese classics dating back 2100 years [3]. It has since
undergonesubstantialdevelopmentandimprovementunder
the auspices of ruling authorities as well as private prac-
titioners in China [4, 5]. TCM survives the displacement
of modern Western medicine and continues to serve as
one of the major CAMs among Far East Asian populations
nowadays. In particular, in China, Japan, Korea and Taiwan,
standardized TCM formulas (TCMFs) have been approved
by the health regulatory agencies and thus covered by the
public health insurance. TCM utilizes natural products,
acupuncture, chiropractic and a combination of them in a
therapeuticcourse.WediscussonlytheTCMusageofnatural
products that have known chemical compositions in this
article.
TCM ascribes an individual’s ailment to an imbalance in
the antagonizing elements in a part (or parts) of the individ-
ual’s body [3, 6–9]. The opposing forces are broadly called
yin and yang. A TCM practitioner diﬀerentiates a patient’s
syndromes into diﬀerent categories of yin or yang deﬁcit.
TCM medicinals (TCMMs), which are characterized into
yin-o ryang-enhancing categories, are then prescribed as a
cure to restore the yin-yang balance [10]. The intangible yin-
yang and other diﬀerentiations, such as emptiness-fullness
and coolness-warmness, ofa patient and the associated TCM
treatments reﬂect in part the limitations of the diagnostic
and clinical techniques of the ancient East in comparison
with the advances in biochemistry and molecular biology
of the modern West. Sustainability and renaissance of TCM2 Evidence-Based Complementary and Alternative Medicine
call for a modernization of TCM, where standardization of
TCMterminologies, materialsandformulasisseenasamong
the ﬁrst endeavors [11, 12]. Our approach toward the goal
considerselucidatingepigeneticmechanisms in TCMMs and
TCMFs. The latter are composed of combinations of the
former and serve as the major form of TCM prescriptions
ap a t i e n tr e c e i v e s[ 13, 14].
Epigenetics refers to mitotically stable changes in gene
expression that do not involve alterations in the underly-
ing DNA sequence. Well-known epigenetic mechanisms in
mammalian cells include methylation of CG dinucleotides,
post-translational modiﬁcations of histone proteins and
RNA interference [15, 16]. For example, DNA methylation,
histone deacetylation and microRNA (miRNA) expression
are associated with gene silencing [17, 18] .T h ep r o ﬁ l eo f
epigenetic marks (epigenome) and miRNA expression of
a cell is sensitive to environmental perturbations [19, 20]
and aberrations in the proﬁle can lead to an increased
predisposition to morbid phenotypes such as Alzheimer’s
disease [21], autoimmune disease [22]a n dh e a r td i s e a s e
[23]. In particular, a genome-wide hypomethylation and
gene-speciﬁc hypermethylation are considered a hallmark of
cancerous cells [24]. Many TCM prescriptions are believed
to exert a long-lasting change to an individual’s constitution.
Furthermore, TCM prescriptions are thought to lack target
speciﬁcity in contrast to the particular receptor/pathway
targeting of modern Western drugs. The former property
of TCM is reminiscent of the maintenance of (acquired)
epigenetic patterns through somatic cell divisions and the
latter of (i) the epigenetic (dys)homeostasis aﬀecting the
entire epigenome and (ii) single miRNA targeting diﬀer-
ent mRNA sequences. The correspondences motivated our
hypothesisofan epigeneticrolein thepharmacologyofTCM
prescriptions.
The hypothesis was addressed in a systematic way by
interrogating a large collection of TCMMs and TCMFs,
which has become achievable in the era of data explo-
sion and open access. Namely, we obtained the infor-
mation about direct interactions between chemicals and
epigenetics-related enzymes from a chemical-protein asso-
ciation database [25], which contains 10288993 pairs of
chemical-protein interactions. We retrieved the information
about the chemicals in TCMMs from two TCMM databases
[26, 27], which together contain 48491 chemicals in 3294
TCMMs.Weobtained,from a governmentdatabase[28],the
compositions of 200 standardized TCMFs, the prescriptions
of which are reimbursed under the public health insurance
in Taiwan.
The human proteins of our attention are known to
be involved in epigenetic regulation and believed to be
expressed in most cell types. They include DNA methyl-
transferase (DNMT), histone deacetylase (HDAC), histone
acetyltransferase (HAT), histone methyltransferase (HMT),
methyl CpG-binding protein (MBD), Polycomb group pro-
tein (PcG), Drosha and Dicer (DICER) and their fami-
lies. The former four catalyze covalent modiﬁcations of
chromatin. MBDs and PcGs (co)localize in heterochromatic
loci. DICER process miRNA precursors to mature miRNA.
Evidence of a TCMM’s modulation of the epigenome and
miRNA was then sought through its interactions with the
human proteins. Characterization of a TCMM, that is,
taxonomical kingdom, TCM nature, TCM ﬂavor and TCM
meridian, is of interest as the characteristics serve as a guide
for its functions [3, 6]. We identiﬁed the overrepresented
characteristics of the epigenome- and miRNA-interacting
TCMMs. A TCMM, based on its role in the formula, can
assume one of the four positions: (i) Monarch targeting
the main syndrome, (ii) Minister strengthening the eﬀect of
the Monarch or addressing the secondary syndromes of the
patient, (iii) Assistant enhancing the curative eﬀect of the
Monarch and Minister or allaying the drastic and toxic eﬀect
of the Monarch and Minister and (iv) Guide harmonizing
or leading the prescription to the oﬀending part of the body
[3, 6]. We investigated if diﬀerent epigenetic mechanisms are
utilized by the TCMMs at diﬀerent positions. We studied if a
TCMF’s epigenome and miRNA interactivity (over the TCM
positions or epigenetic mechanisms) diﬀerentiates its area of
clinical applications. The degree of successful diﬀerentiation
helped provide a quantiﬁcation of the role of epigenetics in
TCM prescription.
2.Methods
2.1. Chemical-Protein Interactions and TCMMs Databases.
The chemical-protein interactions were obtained from the
STITCH database (http://stitch.embl.de/)[ 25], containing
10288993 pairs of chemical and protein associations. Each
pair of association comes with a score for the degree of
evidence for the association. The evidence score ranges
between 999 and 150 for the types of evidence from direct
experimental evidence of chemical-protein binding, manual
annotation of metabolite–protein reactions, chemical-pro-
tein interactions across species, to MEDLINE and OMIM
text mining [25]. Information on TCMMs is mainly from
the government-backedShanghai TCMData Center(STDC)
(http://www.tcm120.com/1w2k/tcm species.asp)[ 26]c o n -
taining information about the natures, ﬂavors, meridians
and chemicals of 8896 TCMMs. We also incorporated the
chemicals data of 50 TCMMs from TCM-ID (http://tcm.cz3
.nus.edu.sg/group/tcm-id/tcmid.asp)[ 27], which contains
1313TCMMs,becausethe50medicinalshavemorechemical
en tri esi nT CM - IDth a ni nST DC.T h eT CM Fsw er ef r omth e
Department of Health, Taiwan (http://www.ccmp.gov.tw/en/
information/formula.asp)[ 28], which lists 200 standardized
TCMFs with the composing medicinals and their weights in
gramsaswellasthedoseoftheformulaperdayingrams.The
weights of the medicinals in the formulas range from 0.15 to
25g with a mean (median) of 3.5 (3.0)g. The 200 daily doses
range from 21 to 39g with a mean (median) of 28.4 (28.0)g.
The chemicals in a TCMM are the very information
f o ru st oe s t a b l i s hi t se p i g e n o m e -a n dm i R N A - i n t e r a c t i v i t y .
Supplementary Figure S1 shows the distribution of the
numbers of chemicals in the TCMMs from the integrated
STDC/TCM-ID database, the median number of chemicals
per TCMM being nine. The CAS registry numbers in STDC
and TCM-ID were translated to PubChem IDs, which areEvidence-Based Complementary and Alternative Medicine 3
usedinSTITCH,usingthePubChemserver(http://pubchem
.ncbi.nlm.nih.gov/).
The 200 TCMFs are made from a total of only 276
diﬀerent TCMMs. Supplementary Figure S2 shows the
distribution of the numbers of medicinals per formula, the
median number being eight. (Note that only 230 of them
were unambiguously and non-redundantly mapped to the
integrated STDC/TCM-ID database due to diﬀerent naming
of TCMM parts/preparations between the systems.) Some
TCMMs are common among the formulas. Supplementary
Figure S3 shows the frequency of medicinals in the 200
formulas. Designation of the formulas to the clinic function
categories is available from the Bureau of National Health
Insurance, Taiwan (http://www.nhi.gov.tw/). Supplementary
Figure S4 shows the distribution of the functional categories
of the 200 formulas.
2.2. Data Analysis
2.2.1. Determination of Epigenetic TCMMs. A medicinal is
DNMT-interacting if it contains chemicals that interact with
the DNMT family proteins, which were identiﬁed from
a search with keywords “DNMT” in the STITCH protein
annotation ﬁle (protein.aliases.v7.1.txt). A medicinal can
contain more than one DNMT-interacting chemical, each
of which may interact with more than one proteins in the
DNMT protein family. The strength of DNMT interaction
of the medicinal was determined by the total number
of such interactions multiplied by the sum of average
evidence score per chemical divided by the total number of
DNMT-interacting chemicals in the STITCH database. The
multiplication is to weight by the evidence. The division is
t oa c c o u n tf o rt h ef a c tt h a ts o m e proteins contain more pairs
of interactions because they are better studied. Procedures
for other epigenetic mechanisms were similar with HDAC
identiﬁed with keywords “histone” and “deacetylase”, HAT
with keywords “histone” and “acetyltransferase”, HMT with
“histone” and “methyltransferase”, MBD with “methyl”,
“CpG” and “binding”, PcG with “polycomb”, and DICER
with “dicer” and “drosha”. The matchings were all case-
insensitive. The numbers of proteins thus identiﬁed in each
o ft h eD N M T ,H D A C ,H A T ,H M T ,M B D ,P c G ,D I C E R
families are respectively 6, 12, 7, 8, 9, 8, 1 and 1. They
are listed in Supplementary Table S1. A medicinal is called
epigenetic if it is X-interacting where X is any of the
seven epigenetic mechanisms. The epigenome- and miRNA-
interactivity of the medicinal is the sum of the seven
interaction strengths.
2.2.2. Determination of Epigenetic TCMFs. A formula is
epigenetic if at least one of its composing medicinal is
epigenetic. The X-interactivity of the formula is obtained
from the sum of strengths of X interaction of the composing
medicinals multiplied by the grams of the medicinals in the
formula.
Further analyses, including determination of a medici-
nal’s TCM position in a formula, are given in online Supple-
mentary Data.
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Figure 1: Epigenome- and miRNA-interactivity of the 981 epi-
genetic TCMMs over epigenetic mechanisms. A row represents
a medicinal.Lighter shades indicatestronger interactivity. Ordering
of the rows was by unsupervised hierarchical clustering. Columns
were ordered according to the prevalence of the mechanism among
the 981 epigenetic TCMMs. Note that DICER includes Drosha and
Dicer in the RNAi pathway.
3.Results
As we are studying the roles of epigenetics in TCM through
chemical-protein interactions, we focus on the TCMMs
that hold non-zero chemical entries in the databases. After
combination of two databases, the number of such TCMMs
is 3294, containing a total of 48 491 chemicals, over 66% of
which are mapped to PubChem. The numbers are the largest
in such materia medica-level studies to our knowledge.
Among the TCMMs, 3284 have taxonomy annotations, in
which 90% are plants, 9% are animals and 1% are minerals.
The proportions are not close to those (69, 18, 13 and 58, 23,
19%) in the classical TCM literature Shen Nong Ben Cao Jing
[6]a n dBen Cao Gang Mu [29], which contain 365 and 1892
TCMMs, respectively. The discrepancy may reﬂect shifts in
TCMM usage away from extinct animals and toxic minerals
toward more diverse and accessible plants.
3.1. Speciﬁcity of TCMMs to Epigenetic Mechanisms. A
TCMM is epigenetic, if at least a chemical in it shows
evidence of direct interaction with any of the epigenetics-
related proteins. We found that 29.8% or 981 out of the 3294
TCMMs are epigenetic. In speciﬁc, a TCMM is X-interacting
if atleast a chemical in it shows evidenceof direct interaction
withproteinsX.Wefound,inFigure 1,thedistributionofthe
operating mechanisms among the 981 epigenetic TCMMs
(epiTCMMs), there being 480 PcG-interacting, 384 MBD-
interacting, 260 HDAC-interacting, 162 HAT-interacting,
149HMT-interacting, 71 DNMT-interacting and 17 DICER-
interacting epiTCMMs. As Figure 1shows, many epiTCMMs
operatethroughonlyoneorfew(1.6±1.0),butnotall,ofthe
mechanisms understudy,suggestingspeciﬁcityofTCMMsto
particular epigenetic mechanisms.4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Kingdom distribution of mechanism-speciﬁc epigenetic
TCMMs. In total, 3284 TCMMs have kingdom annotation.Among
them 980 are epigenetic. More PcG-interacting TCMMs originate
from plants than expected (P = 4.2 × 10−7). More MBD- and HAT-
interacting medicinals are from animals than expected (P = 8.4 ×
10−5 and 1.1 × 10−4,r e s p . ) .
Supplementary Figure S5 plots the proportions of
TCMMs originating from plant,animal and mineral sources.
An overrepresentation analysis (Supplementary Data) indi-
cated that, given the proportions of all the TCMMs in
plants, animals and minerals, epiTCMMs appear slightly
more in plants than expected (P = .041). Furthermore,
when stratifying the epiTCMMs according to the operating
mechanism, we found, in Figure 2, that PcG-interacting
TCMMs are overrepresented in plants (P = 4.2 × 10−7)a n d
MBD- and HAT-interacting TCMMs in animals (P = 8.4 ×
10−5 and 1.1 × 10−4,r e s p . ) .
3.2. Speciﬁcity of Epigenetic TCMMs to TCM Natures, Fla-
vors and Meridians. TCMMs are characterized according
to TCM theories to diﬀerent TCM natures and ﬂavors
[3, 6]. Supplementary Figures S6 and S7 show the nature
and ﬂavor distributions of the TCMMs. Similar to the
taxonomy overrepresentation analysis, sweet epiTCMMs are
found more often than they are expected (P = .0071)
at a P-cutoﬀ of 0.01. A TCMM is also designated its
targeting TCM meridians [29], whose distribution is shown
in Supplementary Figure S8. The overrepresentation analysis
indicated that epiTCMMs target more often kidney and
spleenmeridiansthanexpected(P =.020and.041,resp.).We
also further diﬀerentiated the epiTCMMs by their operating
epigenetic mechanisms. Results of the mechanism-speciﬁc
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Figure 3: Nature distribution of mechanism-speciﬁc epigenetic
TCMMs. In total, 2530 TCMMs have TCM nature annotation.
Among them 818 are epigenetic. At a P-value cutoﬀ of 0.01,
HDAC-interacting TCMMs are overrepresented in neutral (P =
.00041).
overrepresented epiTCMMs are shown in Figures 3, 4,a n d
5.
3.3. Overrepresentation of Epigenetic TCMFs. Clinically rel-
evant TCM prescriptions are in the form of formulas
composed of multiple TCMMs. The role of epigenetics in
TCM is therefore best tested by examining the involvement
of epigenetics in TCMFs. A TCMF is called epigenetic if at
least one of thecomposing TCMMsis epigenetic.Among the
200 standardized TCMFs, 198 were found to be epigenetic.
In Supplementary Data, we calculated the probability, P,o f
getting 198 epigeneticTCMFs(epiTCMFs)ifthe 200 TCMFs
were formed by randomly combining TCMMs from the pool
of TCMMs that form the TCMFs and found P = 2.2 × 10−5.
The small P-value lends support for the proposition of an
epigenetic role in traditional Chinese pharmacy.
Again, if we distinguish the epiTCMFs according to
the mechanism(s) they operate, the pattern of epigenetic
mechanisms in TCMFs is revealed. As Figure 6 shows,
unlike epiTCMMs, an epiTCMF operates via more than one
(5.5 ± 2) mechanisms in delivering the epigenome- and
miRNA-interactivity, reﬂecting the fact that a TCMF is made
up of multiple TCMMs. Figure 6 also shows that histone
modiﬁcations are among the topworking mechanisms in the
198 epiTCMFs. Supplementary Figure S9 sums the degree
of involvement of each mechanism over the 198 epiTCMFs.
Furthermore, the clustering of HAT, HDAC, DICER and ofEvidence-Based Complementary and Alternative Medicine 5
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Figure 4: Top 15 ﬂavor distribution of mechanism-speciﬁc epi-
genetic TCMMs. In total, 2540 TCMMs have ﬂavor annotation.
Among them 822 are epigenetic. DNMT-interacting TCMMs are
overrepresented in sweet (P = 7.1 × 10−5); HDAC-interacting
medicinals in sweet, sweet-sour and sour-sweet (P = 2.4 × 10−5,7 . 5
× 10−5 and 1.7 × 10−3, resp.); HAT-interacting medicinals in bitter-
sweet-astringent (P=8.4 × 10−3); MBD-interacting medicinals
in salty (P = 7.4 × 10−5); PcG-interacting medicinals in sweet-
plain and bitter-astringent (P = 3.8 × 10−3 and 6.7 × 10−3); and
DICER-interacting medicinals in sweet (P = 1.2 × 10−3). The above
overrepresentations are for P < .01.
MBD, DNMT and PcG in Figure 6 provide a tempting hint
at the synergy of epigenetic mechanisms in TCMFs.
3.4. Speciﬁcity of Epigenome-Interactivity to TCM Positions.
In formula design, medicinals are chosen to take the four
positions,Monarch,Minister,Assistant andGuide,according
to the principles of TCM prescription [3, 6]. The role of
a medicinal in a formula therefore can be understood by
its position. We identiﬁed the position of each medicinal
in the 200 formulas and calculated the epigenome- and
miRNA-interactivity of the medicinals occupying the same
position(SupplementaryData).The result inFigures7 and 8
shows that Monarch medicinals are epigenetically distinct in
that Monarch are most epigenome- and miRNA-interacting,
followed by Minister, Assistant and Guide. Furthermore,
Monarch and Assistant medicinals are found epigenetically
least similar among the possible pair-wise comparisons
(Supplementary Table S2).
Since the interactivity was calculated to be proportional
to the degree of evidence of chemical-protein interactions
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Figure 5: Meridian distribution of mechanism-speciﬁc epigenetic
TCMMs. In total, 1155 TCMMs have meridian annotation.Among
them 452 are epigenetic. Note that unlike natures and ﬂavors, a
TCMM canpossess more thanone meridians.DNMT- and HDAC-
interacting TCMMs are overrepresented in spleen (P = .047 and
.039, resp.); HAT-interacting medicinals in pericardium and gall
bladder (P = .034 and .046, resp.); HMT-interacting medicinals in
pericardium and small intestine (P = .024 and .030, resp.); MBD-
interacting medicinals in kidney and liver (P = .011 and .047,
resp.); PcG-interacting medicinals in spleen and lung (P = .038 and
.044, resp.); and DICER-interacting medicinals in pericardium (P =
.031). The above overrepresentations are from P < .05.
deﬁned in [25] (see “Methods” section), we repeated
the analysis using the numbers of epigenetic mechanisms
a medicinal possesses, instead of the numbers of epigenome-
and miRNA-interacting chemicals and the associated evi-
dence score, in the calculation of interactivity. Supplemen-
tary Figures S10a, S11a and Table S2 show the result and
the conclusion that Monarch is epigenetically distinct and
least similar to Assistant remains. Since, according to the
principles of TCM prescription, Monarch medicinals are the
major medicinals against the syndrome and many Assistant
medicinals are antagonistic to the Monarch in order to rein
in the toxicity or side-eﬀects of the Monarch, the results
of an epigenetic uniqueness of Monarch and epigenetic
disparity between Monarch and Assistant may be considered
a demonstration of the principles of TCM prescription.
Figure 8 unfolds the epigenome-and miRNA-interactivity of
the TCMFsoverthemechanisms to revealheavy exploitation
of histone modiﬁcations (cf Figure 6 and Supplementary
Figure S9) by the Monarch. However, the exploitation shifts
to MBD and PcG interactions when scores are not taken into6 Evidence-Based Complementary and Alternative Medicine
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Figure 6: Epigenome- and miRNA-interactivity of the 198 epi-
genetic TCMFs over epigenetic mechanisms. A row represents a
TCMF and a column a mechanism. Rows and columns are ordered
by the unsupervised hierarchical clustering algorithm. Lighter
shades indicate stronger interactivity.
account as shown in Supplementary Figure S11a. Results of
the analysis at the two extreme settings suggest prioritizing
histone modiﬁcations and PcG interaction for experimental
veriﬁcation of TCMF epigenetics.
3.5.Quantiﬁcation of EpigeneticRole in TCMFs. Af u n c t i o n a l
categorization of TCMFs according to the areas of TCM
clinical applications has been developed and widely adopted
since 1682 [30]. Supplementary Figure S4 plots the distri-
bution of the 200 standardized TCMFs across 20 categories
and shows that tonic formulas account for most of the
formulas, followed by ﬁre-purging formulas and dampness-
eliminating formulas, and so forth.
In an eﬀort to quantifying the role of epigenetics in
TCM prescription, our approach lies in answering the
question of how accurately we can determine the functional
category of a formula based solely on its epigenome- and
miRNA-interactivity. To the end, we employed a cross
validation scheme detailed in Supplementary Data. The
result in Figure 9 indicates that epigenetic consideration
plays a sizable role, 19 ± 1%, in prescribing TCMFs for
the various syndromic categories. To assess the signiﬁcance,
we estimated the success rate when the category determi-
nation was randomly made based on the proportion of
the functional categories among the 200 TCMFs. The rate
of success by such random draws was found to be 7 ±
2% (Supplementary Data), which is signiﬁcantly lower than
that by the epigenetic information. Furthermore, Figure 9
indicates that information of the epigenome- and miRNA-
interactions at the four TCMpositions, without the evidence
score, achieved a comparable success rate of 21 ± 1%.
Monarch Minister Assistant Guide
Figure 7: Epigenome- and miRNA-interactivity of the 198 epi-
genetic TCMFs over TCM positions. Rows represent TCMFs and
columns the four TCM positions. The lighter the shades the
stronger the interactivity. Orders of both rows and columns are
arranged by the unsupervised hierarchical clustering algorithm.
Monarch medicinals are distinct from the other positions and least
similar to Assistant.
The result may illustrate the essential role of positions in
formula formation. Note that although the success rate by
mechanism-speciﬁc epigenetic information is higher at 24 ±
1%, its application may not be as handy as the four position
method. Themethod ofTCMFcategorizationvia epigenome
and miRNA interactivity may help in the design of new
formulas. An example is provided in “Discussion” section.
4.Discussion
Epigenetic phenomena have been recognized as a cru-
cial component in the normal development of eukaryotes
including plants [31] and animals [32]. It thus may not
be surprising to ﬁnd that many, that is, 29.8% of the
3294 TCMMs, most of which are derived from plants and
animals, arepotentiallyaﬀectingtheepigenomesandmiRNA
expression of human cells. We chose the proteins for their
well characterization and documentation [33, 34], which
helped support our comprehension of TCMM epigenetics.
For example, eight of the HDAC/HAT-modulating plant
sources (i.e., cashew, licorice, celery, apple, tea, onion,
peanuts and red grapes) reported in the review [35]a r e
included in our 3294 TCMM collection. Among them, all
except one (i.e., cashew) were identiﬁed to be HDAC- or
HAT-interacting through our chemical-protein association
approach. Furthermore, four dietary sources (i.e., tea, soy,
cabbage and turnip) reported to be DNA methylation
modifying in [36] are also in the collection and two of them
(i.e., tea and turnip) were by our approach identiﬁed to be
MBD-interacting, where MBDs were known to interact with
DNMTs [37]. In Supplementary Tables S3–S9, we list all
the identiﬁed epigenetic TCMMs. The tables may serve asEvidence-Based Complementary and Alternative Medicine 7
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Figure 8: Pattern of utilization of epigenetic mechanisms over
TCM positions. Medicinals in a formula can be diﬀerentiated by
their positions in the formula into Monarch, Minister, Assistant
and Guide. The mechanism-speciﬁc interactivity of the Monarch
(and other) medicinals in the 198 epigenetic TCMFs is calculated
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Figure 9: Rate of successful functional categorization of TCMFs
by epigenome- and miRNA-interactivity. TCMFs were classiﬁed
by the mechanism-wise (ﬁrst column) or position-wise (second,
third and fourth columns) epigenome- and miRNA-interactivity.
In the position-wise studies, evidence scores of chemical-protein
interactions (doses of medicinals) were not utilized in the third
(fourth) column. The ﬁfth column is the rate from random
guess based on the proportion of categories among the formu-
las.
a priority list for future experimental veriﬁcation of TCMM
epigenetics.
We identiﬁed the taxonomic kingdoms and TCM na-
tures, ﬂavors and meridians that accommodate more
epiTCMMs than expected (Supplementary Figures S5–S8).
In particular, Figures 2, 3, 4,a n d5 show the mechanism-
speciﬁc epiTCMMs that are overrepresented. A recent study
reported an essential requirement for O-GlcNAc glycosyla-
tionofPolycombproteinstomaintaintranscriptionalrepres-
sion in Drosophila [38]. The result in Figure 4 of overrepre-
sented PcG-interacting TCMMs in sweet-plain ﬂavor may be
a manifestation of such a connection between glycosylation
and PcG function. More studies are needed in this regard.
Our epigenetic analysis of the TCMFs over the positions
revealed a decreasing interactivity from Monarch to Guide.
Since medicinal doses generally decrease gradually from
Monarch to Guide, we repeated the analysis by setting all
the grams to 1. The result, shown in Supplementary Figures
S10b, S11b and Table S2, upholds the ﬁnding that Monarch
medicinals heavily exploit epigenetic mechanisms, followed
by Minister, Assistant and Guide, and that Monarch and
Assistant are epigenetically least similar. In the perspective
of TCM epigenetics, Minister, Assistant and Guide serve
to ﬁne tune the epigenome- and miRNA-interactivity of
the prescription, making multi-medicinal formulas a better
treatment to patients than single medicinals in some cases.
Since medicinal doses in a formula are an essential tuning
parameter for the formula’s function according to the
principles of TCM prescription, on comparing the success
rate of functional prediction with gram information (second
column of Figure 9) to that without grams (fourth column
of Figure 9), indeed we found that the former 19 ± 1%
is slightly higher than the latter 18 ± 1%, consistent with
the principles of TCM prescription. The slight improvement
with grams however may reﬂect the fact that a medicinal’s
position determines its dose. Medicinal dosage therefore
could become redundant given its position.
As we and colleagues recently demonstrated that epige-
netic aberrations play an important role in neurobehavioral
diseases such as schizophrenia, bipolar disorder [39]a n d
Alzheimer’s disease [21], the epigenomes may represent
a promising target for drug development. Indeed, as we
found that most of the 200 basic TCMFs are poten-
tially epigenome- and miRNA-modulating and since many
TCMFs have, on an empirical ground, been considered
eﬃcacious, our ﬁnding further argues for the epigenomes as
a candidate for drug target. As the targets of the epigenetics-
related proteins are multiple and the acquired epigenetic
patterns are mitotically stable, the holistic and long-term
eﬀects of TCM prescriptions can be attributed to TCM
epigenetics. We summarize in Figure 10 the proposed model
of action of TCM prescriptions.
As an example of the applications of TCM epigenetics,
we consider a TCMF that was recently prescribed, as a com-
plementary to the routine Western medicine treatment, for
SARS-likepandemic[40].Theformulaconsistsof13medici-
nals, the position-wise epigenome- and miRNA-interactivity
of which was straightforwardly calculated (Supplementary
Data). By comparing with those of the 200 TCMFs, we8 Evidence-Based Complementary and Alternative Medicine
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Figure 10: A model of the holistic and long-term therapeutic eﬀect of TCM prescriptions. Patterns of epigenetic marks such as DNA
methylation (red) and histone acetylation (green) help maintain the gene expression proﬁle for normal cell functioning. Aberrations in the
epigenetic pattern, due to endogenous or exogenous factors, lead to disorders. Compounds in TCMFs, in particular the Monarch, interact
with the epigenetics-related proteins to restore the altered epigenetic pattern, curing the disorder. Since the epigenetics-related proteins
potentially aﬀect the whole epigenome and the epigenetic pattern, once restored, is passed on to the daughter cells, the holistic (in contrast
to reductionist’s single gene or pathway) and long-term eﬀects of TCM prescriptions are realized.
conclude that the SARS-TCMF prescription is epigenetically
a ﬁre-purging formula. As one of the main symptoms of
SARS is high fever over 38◦C and the combined treatment
was shown in the preliminary study to shorten the days
toward an improvement (in the chest radiography) [40],
we may propose to attribute the beneﬁcial eﬀect of the
combined treatment to the TCMF’s ﬁre-purging function.
Supplementary Tables S3–S9, which list all the epiTCMMs
identiﬁed in the present article, therefore may serve to help
prescribe formulas for emerging syndromes.
A TCMF comprises a number of TCMMs. Moreover, co-
prescription of a TCMF with a TCMM (or another TCMF)
is not uncommon and in fact has been on a rise clinically
[41], possibly responding to the condition of multiple co-
morbidities due to such phenomena as gene–gene interac-
tions. Further studies on prescriptions combining TCMFs
and TCMMs are needed. However, like other approaches,
our current bioinformatics study is not short of limitations.
Since many TCMFs are served in the form of decoctions,
whether the epigenome- and miRNA-modulating chemicals
survive the mixing and processing is unclear. After digestion,
whether the chemicals reach the nuclei of the targeted cells is
not clear. Moreover, missing information about thedirection
of action (activation or inhibition) of chemical-protein
interactions hindered a discussion of the relations among the
variousepigeneticmechanisms intheTCMFs.However,even
although only 30% of the TCMMs are epigenetic, 99% of the
TCMFs are found epigenetic, through mainly the Monarch,
which are known to be the major medicinals in a TCM
prescription. Such a large, pharmacopeial scale analysis of
epigenetics in TCM materials oﬀers a strong support for
the proposition of an epigenetic role in TCM pharmacology.
Epigenetics of TCM may provide a new land for TCM
research.
SupplementaryData
Supplementary data are available at eCAM online.
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